351 related articles for article (PubMed ID: 26412073)
1. The Effects of Calorie Restriction in Depression and Potential Mechanisms.
Zhang Y; Liu C; Zhao Y; Zhang X; Li B; Cui R
Curr Neuropharmacol; 2015; 13(4):536-42. PubMed ID: 26412073
[TBL] [Abstract][Full Text] [Related]
2. Orexin signaling mediates the antidepressant-like effect of calorie restriction.
Lutter M; Krishnan V; Russo SJ; Jung S; McClung CA; Nestler EJ
J Neurosci; 2008 Mar; 28(12):3071-5. PubMed ID: 18354010
[TBL] [Abstract][Full Text] [Related]
3. Effect of caloric restriction on depression.
Manchishi SM; Cui RJ; Zou XH; Cheng ZQ; Li BJ
J Cell Mol Med; 2018 May; 22(5):2528-2535. PubMed ID: 29465826
[TBL] [Abstract][Full Text] [Related]
4. A review of effects of calorie restriction and fasting with potential relevance to depression.
Igwe O; Sone M; Matveychuk D; Baker GB; Dursun SM
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110206. PubMed ID: 33316333
[TBL] [Abstract][Full Text] [Related]
5. The ATP Level in the mPFC Mediates the Antidepressant Effect of Calorie Restriction.
Wang Q; Kong Y; Lin S; Wu DY; Hu J; Huang L; Zang WS; Li XW; Yang JM; Gao TM
Neurosci Bull; 2021 Sep; 37(9):1303-1313. PubMed ID: 34089507
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptides in depression: role of VGF.
Thakker-Varia S; Alder J
Behav Brain Res; 2009 Feb; 197(2):262-78. PubMed ID: 18983874
[TBL] [Abstract][Full Text] [Related]
7. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
[TBL] [Abstract][Full Text] [Related]
8. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.
Nollet M; Leman S
CNS Drugs; 2013 Jun; 27(6):411-22. PubMed ID: 23657787
[TBL] [Abstract][Full Text] [Related]
9. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression.
Nollet M; Gaillard P; Minier F; Tanti A; Belzung C; Leman S
Neuropharmacology; 2011; 61(1-2):336-46. PubMed ID: 21530551
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythms and treatment implications in depression.
Monteleone P; Martiadis V; Maj M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
[TBL] [Abstract][Full Text] [Related]
11. Glutamate hypothesis of depression and its consequences for antidepressant treatments.
Musazzi L; Treccani G; Popoli M
Expert Rev Neurother; 2012 Oct; 12(10):1169-72. PubMed ID: 23082730
[No Abstract] [Full Text] [Related]
12. Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
Gerhard DM; Wohleb ES; Duman RS
Drug Discov Today; 2016 Mar; 21(3):454-64. PubMed ID: 26854424
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
Bortolozzi A; Celada P; Artigas F
Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
[TBL] [Abstract][Full Text] [Related]
14. New investigational agents for the treatment of major depressive disorder.
Pochwat B; Krupa AJ; Siwek M; Szewczyk B
Expert Opin Investig Drugs; 2022 Oct; 31(10):1053-1066. PubMed ID: 35975761
[TBL] [Abstract][Full Text] [Related]
15. Future antidepressants: what is in the pipeline and what is missing?
Bosker FJ; Westerink BH; Cremers TI; Gerrits M; van der Hart MG; Kuipers SD; van der Pompe G; ter Horst GJ; den Boer JA; Korf J
CNS Drugs; 2004; 18(11):705-32. PubMed ID: 15330686
[TBL] [Abstract][Full Text] [Related]
16. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
17. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
18. [Association of obesity and depression].
Rihmer Z; Purebl G; Faludi G; Halmy L
Neuropsychopharmacol Hung; 2008 Oct; 10(4):183-9. PubMed ID: 19213197
[TBL] [Abstract][Full Text] [Related]
19. The rapid-onset antidepressant effect of ketamine: More surprises?
Raffa RB; Pergolizzi JV; Taylor R;
J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
